Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 2038 (108th)

Flu Protection Act of 2004

referredUnited States· United States Congress· EN

Introduced

28 January 2004

Last action

28 January 2004 · Introduced

Status

Read twice and referred to the Committee on Finance.

Sponsors

Sen. Bayh, Evan [D-IN], Sen. Craig, Larry E. [R-ID], Sen. Landrieu, Mary L. [D-LA], Sen. Durbin, Richard J. [D-IL], Sen. Kennedy, Edward M. [D-MA], Sen. Miller, Zell [D-GA], Sen. Mikulski, Barbara A. [D-MD], Sen. Schumer, Charles E. [D-NY], Sen. Kohl, Herb [D-WI], Sen. Dayton, Mark [D-MN], Sen. Byrd, Robert C. [D-WV], Sen. Carper, Thomas R. [D-DE], Sen. Lautenberg, Frank R. [D-NJ]

Subjects

Healthcare, Taxation, Education

Source updated

18 August 2025

Healthcare · Taxation · Education

Summary

Flu Protection Act of 2004 - Amends the Public Health Act to require: (1) the Secretary of Health and Human Services, through the Director of the Centers for Disease Control and Prevention, to conduct annual public influenza awareness campaign and education and outreach (including Medicare outreach) efforts preceding the flu season; (2) the Director to contract with influenza vaccine manufacturers to ensure the availability of additional doses of flu vaccine; (3) the Director to encourage States to develop a contingency immunization plan for high-risk populations in the event of a vaccine delay or shortage; and (4) the Secretary, through the Director, to establish a protocol to attempt to prevent, prepare for, and respond to an influenza epidemic or pandemic. Requires a manufacturer of a vaccine that receives Federal authority to distribute such vaccine to provide the Department of Health and Human Services (HHS) with advance notice of such manufacturer's intent to stop marketplace distribution of the vaccine. Amends the Internal Revenue Code to: (1) establish a vaccine manufacturing facilities investment tax credit (20 percent of qualifying property per year) for property placed in service by December 31, 2008; and (2) define "vaccine manufacturing facilities property."

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 January 2004

    Introduced

    Introduced in Senate

    Source: IntroReferral

  2. 28 January 2004

    Introduced

    Read twice and referred to the Committee on Finance.

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 28 January 2004

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 28 January 2004

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 28 January 2004

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.